GeoVax Partners With ABL To Advance cGMP Production Of Vaccine Candidates
Portfolio Pulse from Happy Mohamed
GeoVax Labs (NASDAQ:GOVX) has signed a Master Services Agreement with Advanced Bioscience Laboratories (ABL) to support cGMP production of its vaccine candidates, including GEO-MVA and GEO-CM04S1. ABL is a subsidiary of Institut Mérieux and specializes in gene therapies, oncolytic viruses, and vaccine candidates.
May 31, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GeoVax Labs partners with ABL for cGMP production of vaccine candidates, potentially accelerating late-stage development and commercialization.
The partnership with ABL, a well-established CDMO, will support GeoVax's cGMP production of its vaccine candidates, including GEO-MVA and GEO-CM04S1. This collaboration could accelerate the late-stage development and eventual commercialization of these candidates, positively impacting GeoVax's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100